ID   SGK3_HUMAN              Reviewed;         496 AA.
AC   Q96BR1; A8K5W3; Q9P1Q7; Q9UKG5;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   05-OCT-2010, entry version 91.
DE   RecName: Full=Serine/threonine-protein kinase Sgk3;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 3;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase-like;
GN   Name=SGK3; Synonyms=SGK2, SGKL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-320, AND
RP   MUTAGENESIS OF SER-486.
RX   MEDLINE=20018032; PubMed=10548550; DOI=10.1042/0264-6021:3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel
RT   isoforms of serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=20054360; PubMed=10585774; DOI=10.1006/geno.1999.5969;
RA   Dai F., Yu L., He H., Zhao Y., Yang J., Zhang X., Zhao S.;
RT   "Cloning and mapping of a novel human Serum/Glucocorticoid regulated
RT   kinase-like gene, SGKL, to chromosome 8q12.3-q13.1.";
RL   Genomics 62:95-97(1999).
RN   [3]
RP   SEQUENCE REVISION.
RA   Zhao Y.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   MEDLINE=22284526; PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [8]
RP   PHOSPHORYLATION AT THR-320 AND SER-486, AND MUTAGENESIS OF ARG-90 AND
RP   LYS-191.
RX   PubMed=16790420; DOI=10.1074/jbc.M604333200;
RA   Tessier M., Woodgett J.R.;
RT   "Role of the Phox homology domain and phosphorylation in activation of
RT   serum and glucocorticoid-regulated kinase-3.";
RL   J. Biol. Chem. 281:23978-23989(2006).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-92.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-355.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the activation of potassium channels.
CC       Mediates cell IL-3-dependent survival signals (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-320) and the other in the C-terminal regulatory region (Ser-
CC       486), need to be phosphorylated for its full activation.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle (By similarity). Early
CC       endosome (By similarity). Note=Localized in vesicle-like
CC       structures and in the early endosome (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues with highest levels
CC       in pancreas, kidney liver, heart and brain and lower levels in
CC       lung, placenta and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 PX (phox homology) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF12758.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169035; AAF12758.1; ALT_INIT; mRNA.
DR   EMBL; AF085233; AAF27051.2; -; mRNA.
DR   EMBL; AK291428; BAF84117.1; -; mRNA.
DR   EMBL; CH471068; EAW86919.1; -; Genomic_DNA.
DR   EMBL; BC015326; AAH15326.1; -; mRNA.
DR   IPI; IPI00655852; -.
DR   RefSeq; NP_001028750.1; -.
DR   RefSeq; NP_037389.4; -.
DR   RefSeq; NP_733827.2; -.
DR   UniGene; Hs.613417; -.
DR   ProteinModelPortal; Q96BR1; -.
DR   SMR; Q96BR1; 10-125, 160-490.
DR   IntAct; Q96BR1; 1.
DR   MINT; MINT-2813751; -.
DR   STRING; Q96BR1; -.
DR   PhosphoSite; Q96BR1; -.
DR   PRIDE; Q96BR1; -.
DR   Ensembl; ENST00000262211; ENSP00000262211; ENSG00000104205.
DR   Ensembl; ENST00000396596; ENSP00000379842; ENSG00000104205.
DR   GeneID; 23678; -.
DR   KEGG; hsa:23678; -.
DR   UCSC; uc003xwr.1; human.
DR   CTD; 23678; -.
DR   GeneCards; GC08P067624; -.
DR   HGNC; HGNC:10812; SGK3.
DR   HPA; HPA027146; -.
DR   MIM; 607591; gene.
DR   PharmGKB; PA35722; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q96BR1; -.
DR   OMA; QNLVRHP; -.
DR   OrthoDB; EOG97H88W; -.
DR   PhylomeDB; Q96BR1; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 46545; -.
DR   Bgee; Q96BR1; -.
DR   CleanEx; HS_SGK2; -.
DR   CleanEx; HS_SGK3; -.
DR   Genevestigator; Q96BR1; -.
DR   GermOnline; ENSG00000104205; Homo sapiens.
DR   GO; GO:0016023; C:cytoplasmic membrane-bounded vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphoinositide binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0007154; P:cell communication; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:3.30.1520.10; PX; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00312; PX; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF64268; PX; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasmic vesicle; Endosome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    496       Serine/threonine-protein kinase Sgk3.
FT                                /FTId=PRO_0000086649.
FT   DOMAIN       12    124       PX.
FT   DOMAIN      162    419       Protein kinase.
FT   DOMAIN      420    496       AGC-kinase C-terminal.
FT   NP_BIND     168    176       ATP (By similarity).
FT   MOTIF       195    205       Nuclear localization signal (By
FT                                similarity).
FT   ACT_SITE    286    286       Proton acceptor (By similarity).
FT   BINDING     191    191       ATP (By similarity).
FT   MOD_RES     126    126       Phosphoserine (By similarity).
FT   MOD_RES     129    129       Phosphoserine (By similarity).
FT   MOD_RES     320    320       Phosphothreonine; by PDPK1.
FT   MOD_RES     486    486       Phosphoserine.
FT   VARIANT      92     92       A -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035636.
FT   VARIANT     355    355       L -> P.
FT                                /FTId=VAR_041076.
FT   MUTAGEN      90     90       R->A: Partially localized to the
FT                                membrane.
FT   MUTAGEN     191    191       K->M: Abolishes activity.
FT   MUTAGEN     486    486       S->D: Increased activation.
FT   CONFLICT     54     54       F -> V (in Ref. 2 and 3).
FT   CONFLICT    127    127       D -> G (in Ref. 2 and 3).
FT   CONFLICT    187    187       F -> V (in Ref. 2 and 3).
FT   CONFLICT    294    294       L -> V (in Ref. 2 and 3).
FT   CONFLICT    387    387       T -> R (in Ref. 2 and 3).
SQ   SEQUENCE   496 AA;  57108 MW;  76A6CCEB69006CF1 CRC64;
     MQRDHTMDYK ESCPSVSIPS SDEHREKKKR FTVYKVLVSV GRSEWFVFRR YAEFDKLYNT
     LKKQFPAMAL KIPAKRIFGD NFDPDFIKQR RAGLNEFIQN LVRYPELYNH PDVRAFLQMD
     SPKHQSDPSE DEDERSSQKL HSTSQNINLG PSGNPHAKPT DFDFLKVIGK GSFGKVLLAK
     RKLDGKFYAV KVLQKKIVLN RKEQKHIMAE RNVLLKNVKH PFLVGLHYSF QTTEKLYFVL
     DFVNGGELFF HLQRERSFPE HRARFYAAEI ASALGYLHSI KIVYRDLKPE NILLDSVGHV
     VLTDFGLCKE GIAISDTTTT FCGTPEYLAP EVIRKQPYDN TVDWWCLGAV LYEMLYGLPP
     FYCRDVAEMY DNILHKPLSL RPGVSLTAWS ILEELLEKDR QNRLGAKEDF LEIQNHPFFE
     SLSWADLVQK KIPPPFNPNV AGPDDIRNFD TAFTEETVPY SVCVSSDYSI VNASVLEADD
     AFVGFSYAPP SEDLFL
//
